TapewireFind a company

person · Reporting owner

Simon Lynn T

Disclosed activity across 2 companies

Tapewire entity
93665
SEC CIK
0001598823

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628President and CMOMarch 01, 2024March 02, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COMMUNITY HEALTH SYSTEMS INC

Report date March 01, 2024 · Filed March 02, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect482,657 Ending reported balance After 2024-03-01 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2024-03-01 · Exercise / conversion · Acquired 80,000 · Balance 489,878

F1: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Row 2 · 2024-03-01 · Grant · Acquired 40,000 · Balance 529,878

F2: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Row 3 · 2024-03-01 · Tax withholding · Disposed 47,221 · Balance 482,657

Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct0 Reported balance After 2024-03-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2024-03-01 · Exercise / conversion · Disposed 80,000 · Balance 0

F1: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct80,000 Reported balance After 2024-03-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2024-03-01 · Grant · Acquired 80,000 · Balance 80,000

F3: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct80,000 Reported balance Holding disclosure · report date 2024-03-01 · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · Balance 80,000

F5: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct80,000 Reported balance Holding disclosure · report date 2024-03-01 · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · Balance 80,000

F6: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.87 · Expires 2034-02-28Direct40,000 Reported balance After 2024-03-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2024-03-01 · Grant · Acquired 40,000 · Balance 40,000

F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.99 · Expires 2029-02-28Direct26,250 Reported balance Holding disclosure · report date 2024-03-01 · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · Balance 26,250

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.93 · Expires 2030-02-28Direct26,250 Reported balance Holding disclosure · report date 2024-03-01 · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · Balance 26,250

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.81 · Expires 2031-02-28Direct40,000 Reported balance Holding disclosure · report date 2024-03-01 · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · Balance 40,000

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.18 · Expires 2032-02-29Direct40,000 Reported balance Holding disclosure · report date 2024-03-01 · row 12 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 12 · Balance 40,000

F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.15 · Expires 2033-02-28Direct40,000 Reported balance Holding disclosure · report date 2024-03-01 · row 13 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 13 · Balance 40,000

F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

F2: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

F3: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F4: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

F5: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F6: The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

KINDRED HEALTHCARE, INC

Report date July 02, 2018 · Filed July 02, 2018

Section 16 reporting ended · disclosed 2018-07-02. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2018-07-02 transaction · row 1
1 source row

Row 1 · 2018-07-02 · Disposition to issuer · Disposed 32,094 · Balance 0

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 6

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2034-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 80,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 47,221 $2.87 $135,524.27
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 482,657

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 529,878

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:57 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024237 · ownership.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 489,878

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $6.15 $0.00
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · derivative · entry 6

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2033-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionPerformance Based Restricted · Derivative 52,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 34,596 $6.15 $212,765.40
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · nonDerivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,878

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,474

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionCommon Stock 52,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-014701 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $10.18 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 6

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-02-29

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionPerformance Based Restricted · Derivative 52,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 53,543 $10.18 $545,067.74
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,884

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 405,427

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 23:02 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionCommon Stock 105,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015010 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,427

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2019-2021 Performance Period, the award vested on March 1, 2022 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/4/2019.

Read SEC document
March 01, 2022 Filed Nov 4, 2022 20:23 UTC Amendment COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 53,453 $10.18 $544,151.54
Disclosure

SEC source: 0001209191-22-055802 · doc4a.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,974

F1 · kind: This Amendment corrects (i) the number of shares of Common Stock forfeited by Reporting Person on 3/1/22 at the closing price of the Company's Common Stock on that date ($10.18/share) as a result of tax withholding associated with the 3/1/22 restricted stock vesting events as well as (ii) the number of shares of Common Stock beneficially owned by Reporting Person. On a Form 4 filed on 3/2/22, the number of shares withheld from Reporting Person as payment of the tax liability resulting from the 3/1/22 vesting events related to prior grants of restricted stock was incorrectly reported as 53,543, rather than the correct figure of 53,453. As a result, the number of shares of Common Stock beneficially owned by Reporting Person was incorrectly reported in Table 1, Column 5 as 351,884, rather than the correct figure of 351,974.

F1 · shares: This Amendment corrects (i) the number of shares of Common Stock forfeited by Reporting Person on 3/1/22 at the closing price of the Company's Common Stock on that date ($10.18/share) as a result of tax withholding associated with the 3/1/22 restricted stock vesting events as well as (ii) the number of shares of Common Stock beneficially owned by Reporting Person. On a Form 4 filed on 3/2/22, the number of shares withheld from Reporting Person as payment of the tax liability resulting from the 3/1/22 vesting events related to prior grants of restricted stock was incorrectly reported as 53,543, rather than the correct figure of 53,453. As a result, the number of shares of Common Stock beneficially owned by Reporting Person was incorrectly reported in Table 1, Column 5 as 351,884, rather than the correct figure of 351,974.

F1 · price: This Amendment corrects (i) the number of shares of Common Stock forfeited by Reporting Person on 3/1/22 at the closing price of the Company's Common Stock on that date ($10.18/share) as a result of tax withholding associated with the 3/1/22 restricted stock vesting events as well as (ii) the number of shares of Common Stock beneficially owned by Reporting Person. On a Form 4 filed on 3/2/22, the number of shares withheld from Reporting Person as payment of the tax liability resulting from the 3/1/22 vesting events related to prior grants of restricted stock was incorrectly reported as 53,543, rather than the correct figure of 53,453. As a result, the number of shares of Common Stock beneficially owned by Reporting Person was incorrectly reported in Table 1, Column 5 as 351,884, rather than the correct figure of 351,974.

F1 · balance_after: This Amendment corrects (i) the number of shares of Common Stock forfeited by Reporting Person on 3/1/22 at the closing price of the Company's Common Stock on that date ($10.18/share) as a result of tax withholding associated with the 3/1/22 restricted stock vesting events as well as (ii) the number of shares of Common Stock beneficially owned by Reporting Person. On a Form 4 filed on 3/2/22, the number of shares withheld from Reporting Person as payment of the tax liability resulting from the 3/1/22 vesting events related to prior grants of restricted stock was incorrectly reported as 53,543, rather than the correct figure of 53,453. As a result, the number of shares of Common Stock beneficially owned by Reporting Person was incorrectly reported in Table 1, Column 5 as 351,884, rather than the correct figure of 351,974.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 40,000 $0.00 Strike: $8.81 $0.00
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 6

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 80,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2021-2023 Performance Period.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionPerformance Based Restricted · Derivative 35,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 39,025 $8.81 $343,810.25
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,427

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 299,452

F2 · price: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2021 Filed Mar 2, 2021 21:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Exercise / conversionCommon Stock 70,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-016080 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 259,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2018 and 12/31/2020 (the "2018-2020 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2018-2020 Performance Period, the award vested on March 1, 2021 at 200% of the target number of the performance-based restricted shares originally reported by the reporting person on 3/2/2018.

Read SEC document
March 01, 2020 Filed Mar 2, 2020 23:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Disposition to issuerPerformance Based Restricted · Derivative 20,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 5

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F4 · derivative.exercise_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited.

F4 · derivative.expiration_date: The vesting of these performance-based restricted shares was subject to the Issuer's attainment of certain performance objectives between 1/1/2017 and 12/31/2019. These performance objectives were not attained so the restricted shares have been forfeited.

Read SEC document
March 01, 2020 Filed Mar 2, 2020 23:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 26,250 $0.00 Strike: $4.93 $0.00
Disclosure

SEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,250

Underlying: Common Stock · 26,250 shares

Expires 2031-02-28

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2020 Filed Mar 2, 2020 23:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 52,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-20-014742 · doc4.xml · derivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2020-2022 Performance Period.

Read SEC document
March 01, 2020 Filed Mar 2, 2020 23:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 10,659 $4.93 $52,548.87
Disclosure

SEC source: 0001209191-20-014742 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,452

Read SEC document
March 01, 2020 Filed Mar 2, 2020 23:41 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 26,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-014742 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,111

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2019 Filed Mar 4, 2019 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantStock Options (Right to Buy) · Derivative 26,250 $0.00 Strike: $4.99 $0.00
Disclosure

SEC source: 0001209191-19-015603 · doc4.xml · derivative · entry 4

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,250

Underlying: Common Stock · 26,250 shares

Expires 2029-02-28

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2019 Filed Mar 4, 2019 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 52,500 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-19-015603 · doc4.xml · derivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,500

Underlying: Common Stock · 52,500 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2019 and 12/31/2021 (the "2019-2021 Performance Period"), as follows: 50% to a Cumulative Same-Store Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2019-2021 Performance Period.

Read SEC document
March 01, 2019 Filed Mar 4, 2019 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 11,806 $4.99 $58,911.94
Disclosure

SEC source: 0001209191-19-015603 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,861

Read SEC document
March 01, 2019 Filed Mar 4, 2019 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 26,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-015603 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,667

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
July 02, 2018 Filed Jul 2, 2018 13:11 UTC KINDRED HEALTHCARE, INC KND · Entity 165258 Disposition to issuerCommon Stock 32,094 $9.00 $288,846.00
Disclosure

SEC source: 0001209191-18-040223 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 35,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015676 · doc4.xml · derivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2028-02-28

F2 · derivative.exercise_date: The vesting of 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The vesting of the remaining 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Margin Improvement for the 2018-2020 Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Adjusted EBITDA Margin Improvement criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 11,806 $4.58 $54,071.48
Disclosure

SEC source: 0001209191-18-015676 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,417

Read SEC document
March 01, 2018 Filed Mar 2, 2018 21:33 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 35,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-015676 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,223

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
May 24, 2017 Filed May 25, 2017 12:08 UTC KINDRED HEALTHCARE, INC KND · Entity 165258 GrantCommon Stock 14,852 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-035207 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,094

F1 · shares: These shares represent restricted stock granted to the reporting person. These shares will fully vest on 5/24/2018.

Read SEC document
March 01, 2017 Filed Mar 2, 2017 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantPerformance Based Restricted · Derivative 20,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-17-016568 · doc4.xml · derivative · entry 3

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2027-02-28

F2 · derivative.exercise_date: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period.

Read SEC document
March 01, 2017 Filed Mar 2, 2017 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 Tax withholdingCommon Stock 17,481 $9.19 $160,650.39
Disclosure

SEC source: 0001209191-17-016568 · doc4.xml · nonDerivative · entry 2

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,223

Read SEC document
March 01, 2017 Filed Mar 2, 2017 21:21 UTC COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-016568 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · President and CQO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,704

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
November 02, 2016 Filed Nov 3, 2016 09:17 UTC KINDRED HEALTHCARE, INC KND · Entity 165258 GrantCommon Stock 17,242 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-148062 · doc4.xml · nonDerivative · entry 1

Simon Lynn T · CIK 0001598823 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,242

F1 · shares: These shares represent restricted stock granted to the reporting person. These shares will fully vest on 11/2/2017.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.